News

WellDoc® Enters Joint Commercial Partnership Agreement with Samsung for BlueStar® C

WellDoc

Digital health technology leader, WellDoc, announced today it has entered a joint commercial partnership agreement with multinational electronics leader, Samsung Electronics, to deliver a best-in-class digital health solution for individuals living with diabetes. The companies will integrate WellDoc’s newly-released consumer diabetes health app, BlueStar® C, with the recently launched Samsung Health, a mobile one-stop shop […]

Comments Off on WellDoc® Enters Joint Commercial Partnership Agreement with Samsung for BlueStar® C Continue Reading →

UMB’s New Ventures Initiative Fosters Commercialization

umventures-logo-trans

Innovative science at the University of Maryland, Baltimore is getting an extra boost through an innovative program fueled by UM Ventures called the “New Ventures Initiative” (NVI), which is headquartered in the Lion Brothers Building.   UMB’s New Ventures Initiative is designed to bring together management expertise, business formation strategy, a physical space, and early-stage capital […]

Comments Off on UMB’s New Ventures Initiative Fosters Commercialization Continue Reading →

Biohealth Innovation Steps Up to Manage 2 Montgomery County Incubators

bhilogo

Building on experience with an accelerator and various other startup resources, the organization will run incubators in Rockville and Germantown. BioHealth Innovation inked a pair of recent deals to run incubators in Montgomery County. The Rockville-based organization that works to help health and life sciences startups in the region is set to manage the Germantown […]

Comments Off on Biohealth Innovation Steps Up to Manage 2 Montgomery County Incubators Continue Reading →

CoapTech, LLC, and University of Maryland, Baltimore Set Stage to Commercialize Novel Procedure for Placing Feeding Tubes

umventures-logo-trans

– Start-up Company Developing Safer, Less Expensive Gastrostomy Method – CoapTech Receives Maryland Innovative Initiative Award to Further Advance the Technology BALTIMORE, Nov. 29, 2016 /PRNewswire/ — University of Maryland (UM) Ventures and CoapTech, LLC, announced today that the University of Maryland, Baltimore (UMB) has granted CoapTech exclusive licensing rights for the commercial development of […]

Comments Off on CoapTech, LLC, and University of Maryland, Baltimore Set Stage to Commercialize Novel Procedure for Placing Feeding Tubes Continue Reading →

GlycoMimetics Joins New Sickle Cell Disease Coalition, Issues Call to Action to Improve Treatment and Care

logo-glyco

GlycoMimetics joins leading patient advocacy groups, researchers, clinicians, policymakers, industry, and foundations in a collective effort to improve sickle cell disease (SCD) care, early diagnosis, treatment, and research both in the United States and globally. The newly formed Sickle Cell Disease Coalition’s first order of business is an international call to action to change the […]

Comments Off on GlycoMimetics Joins New Sickle Cell Disease Coalition, Issues Call to Action to Improve Treatment and Care Continue Reading →

Maryland Economic Development Corporation Partners with BioHealth Innovation, Inc. to Manage Germantown Innovation Center

bhilogo

ROCKVILLE, Md., Oct. 24, 2016 /PRNewswire/ — BioHealth Innovation, Inc. (BHI) announced today that the Maryland Economic Development Corporation (MEDCO), who is the agent for Montgomery County, has selected BHI to manage the Germantown Innovation Center (GIC) located within the Pinkney Innovation Complex for Science and Technology at Montgomery College (PIC MC). The Germantown Innovation […]

Comments Off on Maryland Economic Development Corporation Partners with BioHealth Innovation, Inc. to Manage Germantown Innovation Center Continue Reading →

WBJ: Gaithersburg Rare Disease Startup Vtesse Inc. Nabs $17M in Additional Series A Funding

Vtesse, Inc. logo (PRNewsFoto/Vtesse, Inc.)

Gaithersburg biotech startup Vtesse Inc. — a company with a goal to commercialize National Institutes of Health rare disease drug candidates — secured $17 million in additional Series A funding. Read more via the Washington Business Journal

Comments Off on WBJ: Gaithersburg Rare Disease Startup Vtesse Inc. Nabs $17M in Additional Series A Funding Continue Reading →

VAYA Pharma, a Fast Growing Pioneer in Using Lipids to Treat Disease, Settles in UM BioPark

UMBioPark-Twitter-Profile-Image

Three common disorders that are on the rise worldwide—attention deficit hyperactivity disorder (ADHD), memory loss, and cardiovascular disease—may be more manageable thanks to a growing area of research and development in “medical foods.” And VAYA Pharma, one of the newest BioPark tenants, is developing medical foods that may hold the key to better management of […]

Comments Off on VAYA Pharma, a Fast Growing Pioneer in Using Lipids to Treat Disease, Settles in UM BioPark Continue Reading →